Proactive Investors - Run By Investors For Investors

Feedback expecting significant revenue growth

The investment in new hires for Cadran, along with January's agreement with Future Processing, to accelerate Feedback Medical's technology development and innovation, has increased the company's cost base, the principal benefit of which will not be realised until the next financial year.
Medical professionals studying scans
Investments have been made in order to help drive sales, increase capabilities and improve functionality of Feedback's technology

Feedback PLC (LON:FDBK), the specialist medical imaging technology company, is expecting to report significant revenue growth in the current financial year.

In a short trading update covering trading in the fiscal year to 31 May, the company said the recruitment of new personnel and the investment in product sales in the first half of the financial year had given the top-line the anticipated boost but the real benefit is expected to filter through in the years to come.

In the meantime, that same investment has increased the company's cost base; as a result, the loss for the current financial year will reflect such investment but not the total anticipated income.

The strategic review of the business kicked off earlier this month by the new chief executive officer of the company, Tom Oakley, is still in progress.


View full FDBK profile View Profile

Feedback PLC Timeline

Related Articles

Light fittings
August 23 2018
The group's traditional LED business is operating in a fiercely competitive environment. The group is pinning its hopes on becoming a software and services business
March 20 2019
ITM Power’s first-half results in January showed the hydrogen energy solutions provider has significantly strengthened its capability to deliver larger industrial scale projects
MRI scan
February 22 2019
In February, the firm appointed Dr Tom Oakley, a qualified radiologist and former director of NHS services at telemedicine firm Synergix Health, as the new chief executive of its trading company Feedback Medical

© Proactive Investors 2019

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use